Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

Gastroenterology

Volumn 140, Issue 2, 2011, Pages 478-487.e1

  Bajaj, Jasmohan S ^a,b   Heuman, Douglas M ^a   Wade, James B ^a   Gibson, Douglas P ^a   Saeian, Kia ^b   Wegelin, Jacob A ^a   Hafeezullah, Muhammad ^b   Bell, Debulon E ^a   Sterling, Richard K ^a   Stravitz, R Todd ^a   Fuchs, Michael ^a   Luketic, Velimir ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cirrhosis; Cognitive Function; Driving Performance; IL 10

Indexed keywords

AMMONIA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; RIFAXIMIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; AMMONIA BLOOD LEVEL; ANOREXIA; ARTICLE; CLINICAL ARTICLE; COGNITION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRIVING ABILITY; FLATULENCE; FOLLOW UP; HEADACHE; HEPATIC ENCEPHALOPATHY; HUMAN; INFLAMMATION; INFLUENZA; MINIMAL HEPATIC ENCEPHALOPATHY; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SICKNESS IMPACT PROFILE; SIMULATION; TASK PERFORMANCE; TENESMUS; TREATMENT DURATION; VOMITING; XEROSTOMIA;

EID: 79251535022     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.061     Document Type: Article

References (48)

1. J.S. Bajaj, J.B. Wade, and A.J. Sanyal Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy Hepatology 50 2009 2014 2021
2. P. Ferenci, A. Lockwood, and K. Mullen Hepatic encephalopathydefinition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 2002 716 721
3. J.S. Bajaj, M. Hafeezullah, and R.G. Hoffmann Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy Hepatology 47 2008 596 604
4. G. Kircheis, A. Knoche, and N. Hilger Hepatic encephalopathy and fitness to drive Gastroenterology 137 2009 17061715e19
5. H. Schomerus, W. Hamster, and H. Blunck Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive Dig Dis Sci 26 1981 622 630
6. A. Watanabe, T. Tuchida, and Y. Yata Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability Metab Brain Dis 10 1995 239 248
7. J.S. Bajaj, M. Hafeezullah, and Y. Zadvornova The effect of fatigue on driving skills in patients with hepatic encephalopathy Am J Gastroenterol 104 2009 898 905
8. M. Groeneweg, J.C. Quero, and I. De Bruijn Subclinical hepatic encephalopathy impairs daily functioning Hepatology 28 1998 45 49
9. J.S. Bajaj, M. Hafeezullah, and R.G. Hoffmann Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations Am J Gastroenterol 102 2007 1903 1909
10. J.S. Bajaj, K. Saeian, and M. Hafeezullah Patients with minimal hepatic encephalopathy have poor insight into their driving skills Clin Gastroenterol Hepatol 6 2008 1135 1139 quiz 1065
11. J.S. Bajaj, K. Saeian, and C.M. Schubert Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test Hepatology 50 2009 1175 1183
12. D. Haussinger, and F. Schliess Pathogenetic mechanisms of hepatic encephalopathy Gut 57 2008 1156 1165
13. D.L. Shawcross, G. Wright, and S.W. Olde Damink Role of ammonia and inflammation in minimal hepatic encephalopathy Metab Brain Dis 22 2007 125 138
14. R.K. Dhiman, M.S. Sawhney, and Y.K. Chawla Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy Dig Dis Sci 45 2000 1549 1552
15. S. Prasad, R.K. Dhiman, and A. Duseja Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy Hepatology 45 2007 549 559
16. A. Watanabe, T. Sakai, and S. Sato Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy Hepatology 26 1997 1410 1414
17. P.S. Kamath The need for better clinical trials Hepatology 48 2008 1 3
18. J.S. Bajaj, M. Hafeezullah, and J. Franco Inhibitory control test for the diagnosis of minimal hepatic encephalopathy Gastroenterology 135 2008 15911600e1
19. K. Mullen, P. Ferenci, and N.M. Bass An algorithm for the management of hepatic encephalopathy Semin Liver Dis 27 2007 32 48
20. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
21. P.S. Kamath, and W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
22. T.D. Marcotte, T. Wolfson, and T.J. Rosenthal A multimodal assessment of driving performance in HIV infection Neurology 63 2004 1417 1422
23. C.R. Bowie, and P.D. Harvey Administration and interpretation of the Trail Making Test Nat Protoc 1 2006 2277 2281
24. K.B. Kortte, M.D. Horner, and W.K. Windham The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol 9 2002 106 109
25. J.M. Schear, and S.D. Sato Effects of visual acuity and visual motor speed and dexterity on cognitive test performance Arch Clin Neuropsychol 4 1989 25 32
26. H. Garavan, T.J. Ross, and E.A. Stein Right hemispheric dominance of inhibitory control: an event-related functional MRI study Proc Natl Acad Sci U S A 96 1999 8301 8306
27. T.N. Chase, P. Fedio, and N.L. Foster Wechsler Adult Intelligence Scale performance Cortical localization by fluorodeoxyglucose F 18-positron emission tomography Arch Neurol 41 1984 1244 1247
28. E.K. Warrington, M. James, and C. Maciejewski The WAIS as a lateralizing and localizing diagnostic instrument: a study of 656 patients with unilateral cerebral lesions Neuropsychologia 24 1986 223 239
29. M. Bergner, R.A. Bobbitt, and W.B. Cartner The sickness impact profile: development and final revision of a health status measure Med Care 19 1981 787 805
30. J.J. Jin, H.D. Kim, and J.A. Maxwell Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease J Neuroinflammation 5 2008 23
31. M. Nikodemova, J. Lee, and Z. Fabry Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord J Neuroimmunol 219 2010 33 37
32. J.S. Bajaj, K. Saeian, and K.M. Christensen Probiotic yogurt for the treatment of minimal hepatic encephalopathy Am J Gastroenterol 103 2008 1707 1715
33. S.C. Marshall The role of reduced fitness to drive due to medical impairments in explaining crashes involving older drivers Traffic Inj Prev 9 2008 291 298
34. J. Jacobs, I.O. Korolev, and J.B. Caplan Right-lateralized brain oscillations in human spatial navigation J Cogn Neurosci 22 2010 824 836
35. M.E. Perry, C.R. McDonald, and D.J. Hagler Jr White matter tracts associated with set-shifting in healthy aging Neuropsychologia 47 2009 2835 2842
36. J.M. Oosterman, R.L. Vogels, and B. van Harten Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people Clin Neuropsychol 24 2010 203 219
37. J.D. Cohen, W.M. Perlstein, and T.S. Braver Temporal dynamics of brain activation during a working memory task Nature 386 1997 604 608
38. N.P. Friedman, A. Miyake, and R.P. Corley Not all executive functions are related to intelligence Psychol Sci 17 2006 172 179
39. T.P. Zanto, and A. Gazzaley Neural suppression of irrelevant information underlies optimal working memory performance J Neurosci 29 2009 3059 3066
40. K.R. Lawrence, and J.A. Klee Rifaximin for the treatment of hepatic encephalopathy Pharmacotherapy 28 2008 1019 1032
41. N.M. Bass, K.D. Mullen, and A. Sanyal Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081
42. Y. Iwakiri, and R.J. Groszmann Vascular endothelial dysfunction in cirrhosis J Hepatol 46 2007 927 934
43. P. Lluch, B. Torondel, and P. Medina Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis J Hepatol 41 2004 55 59
44. K.W. Moore, R. de Waal Malefyt, and R.L. Coffman Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765
45. C. Asseman, S. Mauze, and M.W. Leach An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 1999 995 1004
46. P.E. Vos, K.J. Lamers, and J.C. Hendriks Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology 62 2004 1303 1310
47. R.M. Dubinsky, and A.C. Stein Minimal hepatic encephalopathy and driving Hepatology 50 2009 1007 1008
48. R.M. Dubinsky, A.C. Stein, and K. Lyons Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology Neurology 54 2000 2205 2211